Viral origins of human cancer

被引:29
作者
Boccardo, E. [1 ]
Villa, L. L. [1 ]
机构
[1] Ludwig Inst Canc Res, Virol Lab, Sao Paulo Branch, BR-01323930 Sao Paulo, Brazil
关键词
tumor virus; oncogenes; EBV; HBV; HCV; HIV; HTLV-I; HPV;
D O I
10.2174/092986707782023316
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The first consistent observations that viruses could be associated with some types of cancer where made almost a century ago. Since then researchers have spent a great deal of effort to address the infectious origins of human cancer. As a result of these studies, a strong link between some viral agents and several human cancers has been established. Some viruses as the Epstein-Barr virus (EBV), hepatitis B virus (HBV), hepatitis C virus (HCV), human T-cell lymphotropic virus type I (HTLV-I), immunodeficiency virus type I (HIV-I) and several human papillomavirus types (including types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 and 66) have been classified as group I carcinogens by the International Agency for Research in Cancer (IARC). Infection by these viruses constitutes a heavy burden for human populations as it accounts for almost 15% of all human malignancies. Furthermore, many other viral agents have been classified as possibly carcinogenic to humans and others have been occasionally found in human tumors suggesting that this figure may be an underestimation of virus involvement in the etiology of human cancer. Therefore, viral infection appears as one of the main preventable cancer risk factors. We summarize the current state of knowledge concerning virus-induced/associated cancers and discuss its significance in the context of human carcinogenesis. Prevention and control of infection by these agents could dramatically reduce the incidence of some prevalent cancers and, consequently, have a great impact on public health.
引用
收藏
页码:2526 / 2539
页数:14
相关论文
共 354 条
[1]   Transcriptional repression of p21waf1 promoter by hepatitis B virus X protein via a p53-independent pathway [J].
Ahn, JY ;
Chung, EY ;
Kwun, HJ ;
Jang, KL .
GENE, 2001, 275 (01) :163-168
[2]   HPV-associated skin disease [J].
Akgül, B ;
Cooke, JC ;
Storey, A .
JOURNAL OF PATHOLOGY, 2006, 208 (02) :165-175
[3]  
ALTER HJ, 1978, LANCET, V1, P459
[4]   HERPES-LIKE SEQUENCES IN HIV-INFECTED AND UNINFECTED KAPOSIS-SARCOMA PATIENTS [J].
AMBROZIAK, JA ;
BLACKBOURN, DJ ;
HERNDIER, BG ;
GLOGAU, RG ;
GULLETT, JH ;
MCDONALD, AR ;
LENNETTE, ET ;
LEVY, JA .
SCIENCE, 1995, 268 (5210) :582-583
[5]   IDENTIFICATION OF THE HPV-16 E6 PROTEIN FROM TRANSFORMED MOUSE CELLS AND HUMAN CERVICAL-CARCINOMA CELL-LINES [J].
ANDROPHY, EJ ;
HUBBERT, NL ;
SCHILLER, JT ;
LOWY, DR .
EMBO JOURNAL, 1987, 6 (04) :989-992
[6]  
[Anonymous], FIELDS VIROLOGY
[7]   Hepatocellular carcinoma: an overview [J].
Anthony, PP .
HISTOPATHOLOGY, 2001, 39 (02) :109-118
[8]   Thyroid cancer in HCV-related chronic hepatitis patients: A case-control study [J].
Antonelli, Alessandro ;
Ferri, Clodoveo ;
Fallahi, Poupak ;
Pampana, Alessandro ;
Ferrari, Silvia Martina ;
Barani, Lucio ;
Marchi, Santino ;
Ferrannini, Ele .
THYROID, 2007, 17 (05) :447-451
[9]   Thyroid disorders in chronic hepatitis C virus infection [J].
Antonelli, Alessandro ;
Ferri, Clodoveo ;
Fallahi, Poupak ;
Ferrari, Silvia Martina ;
Ghinoi, Alessandra ;
Rotondi, Mario ;
Ferrannini, Ele .
THYROID, 2006, 16 (06) :563-572
[10]   HIV-1 Tat enhances Kaposi sarcoma-associated herpesvirus (KSHV) infectivity [J].
Aoki, Y ;
Tosato, G .
BLOOD, 2004, 104 (03) :810-814